Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Sangamo Therapeutics Inc’s current trading price is -18.36% away from its 52-week high, while its distance from the 52-week low is 315.08%. The stock’s price range over this period has fluctuated between $0.29 and $1.48. The company, operating within the financial sector, had a trading volume of approximately 51.46 million for the day, which was noticeably higher than the average daily share volume of 14.09 million over the last 3 months.
Sangamo Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $1.48 on 02/16/24, while the lowest value for the same period was recorded at $0.29 on 11/13/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Sangamo Therapeutics Inc (SGMO) has experienced a quarterly rise of 115.77% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 251.59M and boasts a workforce of 405 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7118, with a change in price of +0.6748. Similarly, Sangamo Therapeutics Inc recorded 10,547,128 in trading volume during the last 100 days, posting a change of +123.77%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for SGMO stands at 1.23. Similarly, the long-term debt-to-equity ratio is also 1.23.
SGMO Stock Stochastic Average
Today, Sangamo Therapeutics Inc’s raw stochastic average for the past 50 days stands at 69.33%, indicating a rise from the raw stochastic average of the last 20 days, which was 67.44%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 57.87% and 58.65% respectively.
SGMO Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 122.40% this year. Over the last six months, there has been a weaker performance of 131.96%. The price of SGMO fallen by 32.05% during the last 30 days period. For the last 5-days stocks have improved 24.43%.
